—> Look now- TMEB drops Breaking News. Money morning to You!

Recommended Stock Newsletters
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

StockRunway Newsletter

Good Morning Traders, Good Money Morning to all of you. I mean that sincerely as our Big Winning Growth Report: TMEB just dropped Breaking News that could very well impact today`s market session just ahead! Currently trading under two cents, hot press such as this could very well act as a driving force catalyst sending its share price to higher ground in just a blink of an eye! Keep a close eye out now as you research today`s Breaking News below. Right now TMEB appears to be grossly undervalued with incredible upside potential.

We are issuing an immediate potential bounce alert for Terme Bancorp, Inc. (TMEB). All eyes must be on this play because it appears as though support is in place and things could really be turning around. There doesn`t appear to be any resistance until the $0.025 area leaving room for NICE double digit gains from the current price.

Trading volume has been light yet pretty consistent over the past month leaving us to believe that if momentum builds in our favor we could be looking at a clean, profitable bounce play.

► Our Big New First-Class Alert is:

► Terme Bancorp, Inc. – Ticker: TMEB TMEB reported $10.5Mil in Net Income on their last quarterly report! The potential for a nice bounce setup coupled with strong financial numbers in their most recently announced quarterly report leads us to believe that TMEB could be setting up for a major turnaround.

If so, we want you to have the opportunity to capitalize on it first.

Read the Breaking News just released this morning below as it could be the catalyst traders act and react upon today.

Terme Bancorp Relocates Executive Offices to Chicago`s Financial District SUMMIT, IL / ACCESSWIRE / November 3, 2014 / Terme Bancorp (OTC:

TMEB), (“Terme”) a holding company specializing in money services and consumer behavior initiatives, today announced that the Company has relocated its executive offices to Chicago, IL.

Terme Bancorp`s executive offices were previously located in Summit, IL where the Company will remain headquartered while its primary business operations will take place at its new office located at 318 West Adams Street, Suite 1801 in Chicago, IL.

According to Terme`s management, the move was executed to establish a presence in Chicago`s financial district and encourage new business opportunities.

“We are pleased to announce that Terme has relocated its primary operations to downtown Chicago. Being centrally located in one of the nation`s largest cities and financial markets will give the Company direct access to more business opportunities across all of our subsidiary companies and divisions including our money services and mortgage businesses as well as medical and health initiatives,” commented John G. Yedinak, CEO of Terme Bancorp.

Read the full breaking news source right here:

http://clicks.aweber.com/y/ct/l=4k3kt&m=3k3Z9LS.R1976pl&b=DHGV1CK2vM5DdMAQaAgSeA TMEB: One Extremely Lucrative Expanding Industry! Terme Capital`s core business is to provide global electronic money services to consumers by offering general-purpose reloadable (GPR) cards that are sponsored by affinity groups. The primary mission is to provide economic inclusion for a large segment of the population that is under served or rejected by banks and other financial institutions due to their ethnicity or prior banking history.

Terme Capital then collects a small transaction fee for every consumer transaction using their GPR cards and expects to experience early success and generate steady revenue growth in this area of business based on the rapid growth occurring in the electronic currency market.Terme Medical Ventures, Inc.

Terme Medical`s mission is to invest in various consumer-oriented medical initiatives in three specific market segments: Medical MJ, clinical medical devices, and solutions for the treatment of infectious diseases. Terme Medical Venture`s primary focus will be to provide leading technology used to grow and distribute medical MJ and related services while forming lucrative partnerships in this rapidly growing industry.

Additionally, the Company`s management has relationships that will allow Terme Medical Ventures to enter the medical device space.

Terme plans to develop or license clinical device technology that will enable individuals to monitor and improve their overall health. Thirdly, the Company`s new subsidiary intends to form strategic partnerships and relationships with global entities to meet the global demand for treatments and cures for infectious diseasesTerme Mortgage, Inc.

Terme Bancorp reported $10.5Mil in Net Income generated from the purchase of financial services provider, SMC Financial Holdings, Inc. The quarterly report`s financial footnotes explain how Terme realized this income through the forgiveness of debt owed to the seller of the company. All mortgage banking and title company assets acquired in the transactions have been sold or eliminated while elected electronic assets, databases, and personnel have been assimilated into the operations of Terme Mortgage, Inc.

CEO of Terme Bancorp, John G. Yedinak, commented, “As a result of Terme`s acquisition of SMC Financial, we were able to report significant net income of over $10 million during the first quarter which the Company will use to reduce its deferred tax assets and related reserves. These actions, along with Terme`s projected growth in our multiple areas of business should lead to steadily increasing revenues and shareholder value throughout the rest of 2014.” CEO of Terme Bancorp, John G. Yedinak.

TMEB: It`s Upside Potential is Shining Very Bright! See Why…

TMEB is diversifying into industries experiencing significant growth and reported a massive $10.5Mil in Net Income in just one quarter, thanks to the acquisition of SMC Financial Holdings, Inc.

That`s more than most OTC companies report in a whole year.

The chart appears to be turning around and a bounce could be in the works. If TMEB gains momentum in our favor, resistance doesn`t look to be until about $0.032.

If TMEB bounces to this level, it would represent a solid 52% gain from the current price.

Rather consistent volume and a seemingly good risk to reward ratio has us focused on TMEB, as it should you.

Begin researching TMEB now.

The Crew Chief www.StockRunway.com info@StockRunway.com Copyright 2010 StockRunway.com All Rights Reserved. Protected by copyright laws of the United States and international treaties.

This email may only be used pursuant to the subscription agreement controlling use of the StockRunway financial web site and any reproduction, copying, or redistribution of this email or its contents, in whole or in part, is strictly prohibited without the express written permission of StockRunway.com.

LEGAL DISCLAIMER: Neither StockRunway nor any of its employees are registered investment advisors or a Broker/Dealer. As such, StockRunway does not offer or provide personalized investment insight. Although StockRunway may answer general customer service questions, they are not licensed under securities laws to address your particular investment situation. Nothing in this report, nor any communication by our employees to you should be considered personalized investment insight.

This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

StockRunway.com is often times compensated to feature certain companies. These third party, may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.

Release of Liability: Through use of this website viewing or using you agree to hold StockRunway.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.

StockRunway.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. MantleMediaLLC/StockRunway.com expects to be compensated five thousand dollars for the marketing and promotional effort on from a third party shareholder towards this two day featured advertisement article within seven business days from the release of this report..

All information on featured companies is provided by the companies profiled, or is available from public sources and StockRunway.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies.

None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead StockRunway.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks.

Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.

StockRunway.com is compliant with the Can Spam Act of 2003.

StockRunway.com does not offer such advice or analysis, StockRunway.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor`s investment may be lost or impaired due to the speculative nature of the companies profiled.These are paid advertisements used to generate exposure and awareness about the company or companies mentioned in our newsletters.

For full disclaimer please visit our website:

http://clicks.aweber.com/y/ct/l=4k3kt&m=3k3Z9LS.R1976pl&b=JKyrTRiDxs1IoOTjoprtmw Our Ace Pilot lives by one simple measure of success…Yours! 4940 Merrick Rd. Suite 128 Massapequa Park, New York 11758 To

This entry was posted in StockRunway and tagged . Bookmark the permalink.

Comments are closed.